Inventor · disambiguated record
Matthew Ronsheim
Also filed as: RONSHEIM MATTHEW
10 granted patents·13 pending applications·14 citations·filing 2005–2023
83Inventor score
Files withFOREST LAB HOLDINGS LTD5TREVENA INC4FOREST LABORATORIES HOLDINGS LTD3ENANTA PHARM INC2KHAMRAI UTTAM2
Top patents by PatentIndex Score
23 records- 0182US12391658B2Sulfoxide and sulfone glucokinase activators and methods of use thereofVTV THERAPEUTICS LLC·Filed 2021·Granted Aug 19, 2025·1 cites·17 claims
- 0275US9283261B2Linaclotide compositionsFOREST LAB HOLDINGS LTD·Filed 2014·Granted Mar 15, 2016·1 cites·22 claims
- 0375US8349836B2Phthalazine derivatives as inhibitors of protein kinaseARALDI GIAN-LUCA·Filed 2011·Granted Jan 8, 2013·5 cites·15 claims
- 0475US7563797B2Substituted imidazo(1,2-A)pyrimidines and imidazo(1,2-A) pyridines as cannabinoid receptor ligandsFOREST LAB HOLDING LTD·Filed 2007·Granted Jul 21, 2009·5 cites·10 claims
- 0572US7501438B2Pyridoimidazole derivativesFOREST LAB HOLDINGS LTD·Filed 2007·Granted Mar 10, 2009·1 cites·24 claims
- 0671US8044041B2Phthalazine derivatives as inhibitors of protein kinaseFOREST LAB HOLDINGS LTD·Filed 2007·Granted Oct 25, 2011·1 cites·32 claims
- 0766US10851070B2Processes for the resolution of benzodiazepin-2-one and benzoazepin-2-one derivativesENANTA PHARM INC·Filed 2019·Granted Dec 1, 2020·0 cites·15 claims
- 0861US10501422B2Processes for the resolution of benzodiazepin-2-one and benzoazepin-2-one derivativesENANTA PHARM INC·Filed 2018·Granted Dec 10, 2019·0 cites·22 claims
- 0959US2017281774A1Linaclotide compositionsFOREST LABORATORIES HOLDINGS LTD·Filed 2017·Application pending·0 cites
- 1057US2025352521A1Fixed dosage antibiotic compositionsENTASIS THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1156US2016324968A1Linaclotide compositionsFOREST LABORATORIES HOLDINGS LTD·Filed 2016·Application pending·0 cites
- 1256US2025368644A1Durlobactam crystalline formsDURAND REVILLE THOMAS FRANCOIS·Filed 2023·Application pending·0 cites
- 1355US2020222541A1Linaclotide compositionsFOREST LABORATORIES HOLDINGS LTD·Filed 2019·Application pending·0 cites
- 1451US2008300390A1Reducing carbohydrate derivatives of adamantane amines, and synthesis and methods of use thereofFOREST LAB HOLDINGS LTD·Filed 2008·Application pending·0 cites
- 1550US2008153810A1Indazole derivatives useful as melanin concentrating receptor ligandsFOREST LAB HOLDINGS LTD·Filed 2007·Application pending·0 cites
- 1645US9611293B2Synthesis of beta-arrestin effectorsTREVENA INC·Filed 2015·Granted Apr 4, 2017·0 cites·12 claims
- 1745US2006211650A1Reducing carbohydrate derivatives of adamantane amines, and synthesis and methods of use thereofFOREST LABORATORIES·Filed 2005·Application pending·0 cites
- 1844US2018016301A1Synthesis of Beta-Arrestin EffectorsTREVENA INC·Filed 2017·Application pending·0 cites
- 1943US2010168080A1Novel compounds useful as cc chemokine receptor ligandsKHAMRAI UTTAM·Filed 2009·Application pending·0 cites
- 2042US9518086B2Crystalline and amorphous forms of a β-arrestin effectorTREVENA INC·Filed 2015·Granted Dec 13, 2016·0 cites·25 claims
- 2140US2010240611A1Methods for preparing dpp-iv inhibitor compoundsRONSHEIM MATTHEW·Filed 2010·Application pending·0 cites
- 2238US2017283464A1Crystalline And Amorphous Forms Of A Beta-Arrestin EffectorTREVENA INC·Filed 2016·Application pending·0 cites
- 2337US2010152160A1Novel benzodioxane and benzoxazine derivatives useful as cc chemokine receptor ligandsKHAMRAI UTTAM·Filed 2009·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →